Illegal drug use could account for 1 million visits a year to emergency care in England

November 16, 2005

Illegal drug use could account for up to 1 million visits a year to emergency care departments and 400,000 admissions to hospital in England, suggests research in Emergency Medicine Journal.

The findings are based on anonymous interviews with patients visiting an inner city hospital emergency care department in South West England during a typical week.

The treating doctor was also asked to assess whether the patient's need for treatment was indirectly or directly related to illicit drug use.

In all, 1070 patients sought emergency care during the week, 801 of whom were interviewed.

Over a third (36%) admitted to illicit drug use at some time during their lives, and 16% said they had used illegal drugs in the previous month. Almost one in 10 said they had "used" within the previous 24 hours.

The treating doctor judged that the reason for seeking emergency care was directly or indirectly related to their drug use in just under 7% of cases.

Twenty-three patients had to be admitted to hospital, representing just under 3% of all those interviewed. The most common reasons for admission included self harm, skin infections, chest pain and deep vein thrombosis.

The authors say the findings of lifetime illegal drug use more or less match those reported in the British Crime Survey. But the figures for drug use within the preceding month are nearly three times as high. This suggests that recent or current drug use greatly increases the risk of requiring emergency care, they say.

"...with annual Emergency Department attendances currently exceeding 14 million in England alone, it is possible that illegal drugs contribute directly or indirectly to 1 million ED attendances and 40,000 acute hospital admissions in England each year," they conclude.
-end-


BMJ Specialty Journals

Related Drug Articles from Brightsurf:

New drug that can prevent the drug resistance and adverse effects
A research team in Korea is garnering attention for having developed an anticancer drug that could potentially prevent drug resistance.

Potent drug supply drop, not domestic drug policies, likely behind 2018 OD death downturn
The slight decline in drug overdose deaths in 2018 coincides with Chinese regulations on the powerful opioid carfentanil, rather than the result of domestic U.S. efforts to curb the epidemic, a new analysis reveals.

Old drug standards delay new drug approvals
The more information the FDA has about existing drugs, the longer it takes to OK new ones for the same conditions.

What drug companies spend to bring a new drug to market
Researchers estimated the cost to bring 63 new drugs or biologics to market between 2009 and 2018 using publicly available data on research and development expenditures for these medicines.

New flu drug drives drug resistance in influenza viruses
University of Wisconsin-Madison researchers examined the effects of baloxavir treatment on influenza virus samples collected from patients before and after treatment.

Cause of drug resistance in a drug resistance in intestinal tumors identified
Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.

AI could offer warnings about serious side effects of drug-drug interactions
Researchers at Penn State have developed a machine learning system that may be able to warn doctors and patients about possible negative side effects that might occur when drugs are mixed.

Charcoal-based drug delivery system improves efficacy of common herpes drug
A study led by researchers from the University of Illinois at Chicago has found that combining acyclovir -- a commonly prescribed topical herpes medication -- with particles of activated carbon improves efficacy of the drug.

Candida auris is a new drug-resistant fungus emerging globally and in the US early detection is key to controlling spread of deadly drug-resistant fungus
Early identification of Candida auris, a potentially deadly fungus that causes bloodstream and intra-abdominal infections, is the key to controlling its spread.

Arming drug hunters, chemists design new reaction for drug discovery
Colorado State University organic chemists have forged a powerful new tool for drug hunters -- a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

Read More: Drug News and Drug Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.